LabCompass

Christoph Konradt

Immunology and Microbiology · Purdue University West Lafayette

Mid career · publishing since 2010

Publications

22

Citations

1,797

Est. group size

Recurring co-author estimate

Active years

17

Publishing since 2010

Research summary
AI-generated

Christoph Konradt studies how the immune system responds to infections, with a particular focus on the parasite Toxoplasma gondii and how it interacts with the brain and blood vessels. Their work also examines regulatory T cells (a type of immune cell that dampens immune responses) and checkpoint proteins like PD-1/PD-L1, which control how strongly the immune system reacts during infection and in engineered immune therapies. Additional work has touched on platelets, blood vessel barrier function, and CAR T cell cancer therapies.

Toxoplasma gondii infection and immunityRegulatory T cells and immune checkpoints (PD-1/PD-L1)Central nervous system infection and neuroimmunologyEndothelial cells and vascular immunologyCell-based immunotherapy (CAR T cells)

Publication output was steady at 2-3 papers per year from 2017-2020 but has slowed considerably since 2021, with only occasional single publications through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 0.6/year recently
2017: 3 publications3172018: 3 publications3182019: 2 publications192020: 2 publications20212022: 1 publication2223242025: 1 publication252026: 1 publication26
Recent publications
Publishes in
  • The Journal of Immunology×5
  • Nature Microbiology×2
  • Molecular Therapy — Oncolytics×1
  • Cell Reports×1
  • Nature Immunology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile